Literature DB >> 24990952

Phospholipase D and the maintenance of phosphatidic acid levels for regulation of mammalian target of rapamycin (mTOR).

David A Foster1, Darin Salloum2, Deepak Menon2, Maria A Frias2.   

Abstract

Phosphatidic acid (PA) is a critical metabolite at the heart of membrane phospholipid biosynthesis. However, PA also serves as a critical lipid second messenger that regulates several proteins implicated in the control of cell cycle progression and cell growth. Three major metabolic pathways generate PA: phospholipase D (PLD), diacylglycerol kinase (DGK), and lysophosphatidic acid acyltransferase (LPAAT). The LPAAT pathway is integral to de novo membrane phospholipid biosynthesis, whereas the PLD and DGK pathways are activated in response to growth factors and stress. The PLD pathway is also responsive to nutrients. A key target for the lipid second messenger function of PA is mTOR, the mammalian/mechanistic target of rapamycin, which integrates both nutrient and growth factor signals to control cell growth and proliferation. Although PLD has been widely implicated in the generation of PA needed for mTOR activation, it is becoming clear that PA generated via the LPAAT and DGK pathways is also involved in the regulation of mTOR. In this minireview, we highlight the coordinated maintenance of intracellular PA levels that regulate mTOR signals stimulated by growth factors and nutrients, including amino acids, lipids, glucose, and Gln. Emerging evidence indicates compensatory increases in one source of PA when another source is compromised, highlighting the importance of being able to adapt to stressful conditions that interfere with PA production. The regulation of PA levels has important implications for cancer cells that depend on PA and mTOR activity for survival.
© 2014 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Diacylglycerol Kinase; Lipid Metabolism; Lysophosphatidic Acid Acyltransferase; Mammalian Target of Rapamycin (mTOR); Phosphatidic Acid; Phospholipase D; glycolysis

Mesh:

Substances:

Year:  2014        PMID: 24990952      PMCID: PMC4132766          DOI: 10.1074/jbc.R114.566091

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  71 in total

1.  The phospholipase D1 pathway modulates macroautophagy.

Authors:  Claudia Dall'Armi; Andrés Hurtado-Lorenzo; Huasong Tian; Etienne Morel; Akiko Nezu; Robin B Chan; W Haung Yu; Kimberly S Robinson; Oladapo Yeku; Scott A Small; Karen Duff; Michael A Frohman; Markus R Wenk; Akitsugu Yamamoto; Gilbert Di Paolo
Journal:  Nat Commun       Date:  2010       Impact factor: 14.919

2.  Regulation of G1 Cell Cycle Progression: Distinguishing the Restriction Point from a Nutrient-Sensing Cell Growth Checkpoint(s).

Authors:  David A Foster; Paige Yellen; Limei Xu; Mahesh Saqcena
Journal:  Genes Cancer       Date:  2010-11

Review 3.  Phosphatidic acid, a key intermediate in lipid metabolism.

Authors:  K Athenstaedt; G Daum
Journal:  Eur J Biochem       Date:  1999-11

4.  Insulin stimulates phospholipase D-dependent phosphatidylcholine hydrolysis, Rho translocation, de novo phospholipid synthesis, and diacylglycerol/protein kinase C signaling in L6 myotubes.

Authors:  M L Standaert; G Bandyopadhyay; X Zhou; L Galloway; R V Farese
Journal:  Endocrinology       Date:  1996-07       Impact factor: 4.736

5.  Modulation of the mammalian target of rapamycin pathway by diacylglycerol kinase-produced phosphatidic acid.

Authors:  Antonia Avila-Flores; Teresa Santos; Esther Rincón; Isabel Mérida
Journal:  J Biol Chem       Date:  2005-01-04       Impact factor: 5.157

6.  Identification of a novel human lysophosphatidic acid acyltransferase, LPAAT-theta, which activates mTOR pathway.

Authors:  Wenwen Tang; Jian Yuan; Xinya Chen; Xiuting Gu; Kuntian Luo; Jie Li; Bo Wan; Yingli Wang; Long Yu
Journal:  J Biochem Mol Biol       Date:  2006-09-30

7.  PERK utilizes intrinsic lipid kinase activity to generate phosphatidic acid, mediate Akt activation, and promote adipocyte differentiation.

Authors:  Ekaterina Bobrovnikova-Marjon; Dariusz Pytel; Matthew J Riese; Laura Pontano Vaites; Nickpreet Singh; Gary A Koretzky; Eric S Witze; J Alan Diehl
Journal:  Mol Cell Biol       Date:  2012-04-09       Impact factor: 4.272

8.  Mutant ras elevates dependence on serum lipids and creates a synthetic lethality for rapamycin.

Authors:  Darin Salloum; Suman Mukhopadhyay; Kaity Tung; Aleksandra Polonetskaya; David A Foster
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

9.  v-Src increases diacylglycerol levels via a type D phospholipase-mediated hydrolysis of phosphatidylcholine.

Authors:  J G Song; L M Pfeffer; D A Foster
Journal:  Mol Cell Biol       Date:  1991-10       Impact factor: 4.272

10.  Regulation of mTORC1 and mTORC2 complex assembly by phosphatidic acid: competition with rapamycin.

Authors:  Alfredo Toschi; Evan Lee; Limei Xu; Avalon Garcia; Noga Gadir; David A Foster
Journal:  Mol Cell Biol       Date:  2008-12-29       Impact factor: 4.272

View more
  53 in total

Review 1.  Intramuscular Anabolic Signaling and Endocrine Response Following Resistance Exercise: Implications for Muscle Hypertrophy.

Authors:  Adam M Gonzalez; Jay R Hoffman; Jeffrey R Stout; David H Fukuda; Darryn S Willoughby
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

2.  Phosphatidic acid drives mTORC1 lysosomal translocation in the absence of amino acids.

Authors:  Maria A Frias; Suman Mukhopadhyay; Elyssa Lehman; Aleksandra Walasek; Matthew Utter; Deepak Menon; David A Foster
Journal:  J Biol Chem       Date:  2019-11-24       Impact factor: 5.157

Review 3.  The phospholipase D superfamily as therapeutic targets.

Authors:  Michael A Frohman
Journal:  Trends Pharmacol Sci       Date:  2015-02-03       Impact factor: 14.819

Review 4.  The Enigma of Rapamycin Dosage.

Authors:  Suman Mukhopadhyay; Maria A Frias; Amrita Chatterjee; Paige Yellen; David A Foster
Journal:  Mol Cancer Ther       Date:  2016-02-25       Impact factor: 6.261

5.  Rapid mitogenic regulation of the mTORC1 inhibitor, DEPTOR, by phosphatidic acid.

Authors:  Mee-Sup Yoon; Christina L Rosenberger; Cong Wu; Nga Truong; Jonathan V Sweedler; Jie Chen
Journal:  Mol Cell       Date:  2015-04-30       Impact factor: 17.970

Review 6.  Regulation of mTORC1 by PI3K signaling.

Authors:  Christian C Dibble; Lewis C Cantley
Journal:  Trends Cell Biol       Date:  2015-07-06       Impact factor: 20.808

7.  Reciprocal regulation of AMP-activated protein kinase and phospholipase D.

Authors:  Suman Mukhopadhyay; Mahesh Saqcena; Amrita Chatterjee; Avalon Garcia; Maria A Frias; David A Foster
Journal:  J Biol Chem       Date:  2015-01-29       Impact factor: 5.157

8.  Measuring Phospholipase D Enzymatic Activity Through Biochemical and Imaging Methods.

Authors:  F Philip; E E Ha; M A Seeliger; M A Frohman
Journal:  Methods Enzymol       Date:  2016-10-22       Impact factor: 1.600

9.  Thematic minireview series on phospholipase D and cancer.

Authors:  Julian Gomez-Cambronero; George M Carman
Journal:  J Biol Chem       Date:  2014-07-02       Impact factor: 5.157

10.  5-Aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) enhances the efficacy of rapamycin in human cancer cells.

Authors:  Suman Mukhopadhyay; Amrita Chatterjee; Diane Kogan; Deven Patel; David A Foster
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.